In the Margins
Concentrated bets on individual stocks raise issues for mutual funds and their investors—a matter highlighted last week at Sequoia Fund, one of the biggest investors in controversial drug maker Valeant Pharmaceuticals International Inc. Placing outsize bets on well-chosen stocks can lead to strong performance, but concentration increases the riskiness of a fund and raises questions about how much is too much. Read the original story from The Wall Street Journal.
Most Read
As the end of the year approaches, there are several issues that are likely to come up for discussion between chief compliance officers and mutual fund ...
Independent mutual fund directors are required to assess the reasonableness of the profits the management company earns from its advisory contract. It’s a challenging task, since ...
Blockchain has been likened to the “second generation” of the internet. The technology, including digital assets such as coins, tokens and related derivatives, has the potential ...
Five of the seven independent directors overseeing Alliance Bernstein's 94 mutual funds are 70 years old or older, and Chairman Marshall Turner is just fine with ...